 Connection
Lisa Bero to Deprescriptions
This is a "connection" page, showing publications Lisa Bero has written about Deprescriptions.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.982 |
|
|
|
-
Langford AV, Bero L, Lin CC, Blyth FM, Doctor JN, Holliday S, Jeon YH, Moullin JC, Murnion B, Nielsen S, Penm J, Reeve E, Reid S, Wale J, Osman R, Gnjidic D, Schneider CR. Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. J Clin Epidemiol. 2024 Jan; 165:111204.
Score: 0.214
-
Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Schneider CR, Gnjidic D. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023 07 17; 219(2):80-89.
Score: 0.209
-
Langford AV, Schneider CR, Lin CC, Bero L, Collins JC, Suckling B, Gnjidic D. Patient-targeted interventions for opioid deprescribing: An overview of systematic reviews. Basic Clin Pharmacol Toxicol. 2023 Dec; 133(6):623-639.
Score: 0.204
-
Langford AV, Gnjidic D, Lin CC, Bero L, Blyth F, Penm J, Schneider CR. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. 2021 11 01; 162(11):2686-2692.
Score: 0.187
-
Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021 02; 30(2):133-140.
Score: 0.167
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|